Benitec Biopharma (BNTC) Leases: 2019-2025

Historic Leases for Benitec Biopharma (BNTC) over the last 5 years, with Mar 2025 value amounting to $964,000.

  • Benitec Biopharma's Leases rose 187.76% to $964,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $964,000, marking a year-over-year increase of 187.76%. This contributed to the annual value of $270,000 for FY2024, which is 48.67% down from last year.
  • Per Benitec Biopharma's latest filing, its Leases stood at $964,000 for Q1 2025, which was up 603.65% from $137,000 recorded in Q4 2024.
  • In the past 5 years, Benitec Biopharma's Leases registered a high of $964,000 during Q1 2025, and its lowest value of $137,000 during Q4 2024.
  • In the last 3 years, Benitec Biopharma's Leases had a median value of $400,000 in 2023 and averaged $432,000.
  • In the last 5 years, Benitec Biopharma's Leases spiked by 228.57% in 2022 and then crashed by 65.75% in 2024.
  • Quarterly analysis of 5 years shows Benitec Biopharma's Leases stood at $888,000 in 2021, then dropped by 26.80% to $650,000 in 2022, then plummeted by 38.46% to $400,000 in 2023, then tumbled by 65.75% to $137,000 in 2024, then skyrocketed by 187.76% to $964,000 in 2025.
  • Its Leases stands at $964,000 for Q1 2025, versus $137,000 for Q4 2024 and $204,000 for Q3 2024.